96-1513. Product and Establishment License Applications, Refusal to File; Meeting of Oversight Committee; Cancellation  

  • [Federal Register Volume 61, Number 19 (Monday, January 29, 1996)]
    [Notices]
    [Page 2836]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 96-1513]
    
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    
    Product and Establishment License Applications, Refusal to File; 
    Meeting of Oversight Committee; Cancellation
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is announcing 
    cancellation of the meeting for January 1996 of its standing oversight 
    committee (the committee) in the Center for Biologics Evaluation and 
    Research (CBER) that conducts a periodic review of CBER's use of its 
    refusal to file (RTF) practices on product license applications (PLA's) 
    and establishment applications (ELA's). The meeting is being cancelled 
    because there were no RTF actions taken by CBER in the previous 
    quarter. CBER's RTF oversight committee examines all RTF decisions 
    which occurred during the previous quarter to assess consistency across 
    CBER offices and divisions in RTF decisions.
    
    DATES: The meeting scheduled for January 1996 is cancelled. The next 
    meeting is scheduled for April 1996.
    
    FOR FURTHER INFORMATION CONTACT: Joy A. Cavagnaro, Center for Biologics 
    Evaluation and Research (HFM-2), Food and Drug Administration, 1401 
    Rockville Pike, Rockville, MD 20852-1448, 301-827-0372.
    
    SUPPLEMENTARY INFORMATION: In the Federal Register of May 15, 1995 (60 
    FR 25920), FDA announced the establishment of a standing oversight 
    committee in CBER to conduct periodic reviews of CBER's use of its RTF 
    practices on PLA's and ELA's. The May 15 notice stated that the 
    committee meetings would be held quarterly to review all of the RTF 
    decisions. The January 1996 committee meeting is being cancelled 
    because there were no RTF actions taken by CBER in the previous 
    quarter.
    
        Dated: January 22, 1996.
    William K. Hubbard,
    Associate Commissioner for Policy Coordination.
    [FR Doc. 96-1513 Filed 1-26-96; 8:45 am]
    BILLING CODE 4160-01-F
    
    

Document Information

Published:
01/29/1996
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
96-1513
Dates:
The meeting scheduled for January 1996 is cancelled. The next meeting is scheduled for April 1996.
Pages:
2836-2836 (1 pages)
PDF File:
96-1513.pdf